FDA clears group B strep test from Becton

03/29/2012 | Reuters

The FDA has granted Becton, Dickinson and Co. clearance for its BD MAX GBS Assay, an in vitro diagnostic test used to detect group B Streptococcus in Lim Broth cultures. The company also earned Clinical Laboratory Improvement Amendments moderate complexity test status from the agency for its second-generation BD MAX technology.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA